Risk Evaluation and Mitigation Strategies: Developing REMS (CE) in Alignment with the Standards for Commercial Support

Publish Date: 
Monday, January 23, 2012
Last Revised: 
Monday, January 23, 2012

This presentation slide set was delivered by representatives from the ACCME, the Food and Drug Administration, and AstraZeneca during the session entitled "Risk Evaluation and Mitigation Strategies:  Developing REMS (CE) in Alignment with the Standards for Commercial Support" at the Alliance for Continuing Education in the Health Professions Annual Meeting, January 2012, in Orlando, FL.